Close Menu

Beckman Coulter

Beckman will offer services using Agilent's SureSelect Target Enrichment System for next-generation sequencing.

Beckman Coulter's diagnostics sales were up 11 percent, with a strong contribution from the Olympus diagnostics business, while life sciences sales declined.

Analyst Peter Lawson has initiated coverage for the bank of the molecular diagnostics market and has issued reports on Beckman Coulter, Becton Dickinson, Cepheid, Gen-Probe, PerkinElmer, and Qiagen.

The Chairman, President, and CEO resigned yesterday, but the firm did not provide the reasons for his exit.

Avantra was founded last year by Courtagen Capital Group to commercialize the assets of Decision Biomarkers, a protein biomarker technology firm that shuttered its business and filed for Chapter 7 bankruptcy in December 2009.

The firm's revenues were aided by a $116.6 million contribution from Olympus Diagnostics, which the firm bought last year. It missed analysts' estimates and offered a disappointing forecast, sending its shares down sharply.

New Products: Jul 13, 2010

Premium

Beckman DNAdvance SP, Applied Biosystems 3500 Dx Series Genetic Analyzer

Paired Ends: Jul 6, 2010

Premium

Nick Naclerio, Douglas White, Fred Walder, Yemi Adesokan, Graeme Doran, Bill Cook, Sabrina Haas, John Boyce, Jessica Tonani, Andre Marion, William Shanahan

New Products: Jun 29, 2010

Premium

Beckman Coulter's SPRIworks II, Epicenter Biotechnologies' rRNA removal kit, SoftGenetics' NextGENe

Last year, the consortium, which involves researchers, funding agencies, and industry representatives from Canada, Chile, and Norway, awarded a $6 million contract to Beckman Coulter Genomics for the first phase of the project, which uses Sanger sequencing.

Pages

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.